Mikroorganizmy komensaliczne u ssakow - wybrane dane

• Autorzy: Sliwa-Dominiak J , Deptula W.

Warianty tytułu

EN

Commensal microbes in mammals - selected facts

• Języki publikacji: PL

Abstrakty

EN

The paper presents selected facts concerning the role of commensal microorganisms in mammals. The significance of these microorganisms, found on the skin, in the gastrointestinal tract and the respiratory system, has been described. Both the positive and negative consequences of their presence in mammals have been discussed.

Słowa kluczowe

PL

ssaki; skora; przewod pokarmowy; uklad oddechowy; mikroorganizmy komensaliczne; bakterie komensaliczne; wystepowanie; sklad gatunkowy

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2010
• Tom: 66
• Numer: 06
• Opis fizyczny: s.383-388,tab.,bibliogr.

Twórcy

autor

Sliwa-Dominiak J

• Uniwersytet Szczecinski, ul.Felczaka 3c, 71-412 Szczecin

autor

Deptula W.

Bibliografia

• 1. Algood H. M., Cover T. L.: Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin. Microbial. Rev. 2006, 19, 597-613.
• 2. Artis D.: Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 2008, 8, 411-420.
• 3. Blaser M. J., Atherton J. C.: Helicobacter pylori persistence: biology and disease. J. Clin. Invest. 2004, 113, 321-333.
• 4. Brown G. D.: Dectin-1: a signaling non-TLR pattern-recognition receptor. Nat. Rev. Immunol. 2006, 6, 33-43.
• 5. Cash H. L., Whitham C. V., Behrendt C. L., Hooper L. V.: Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313, 1126-1130.
• 6. Chen Y., Blaser M. J.: Inverse associations of Helicobacter pylori with asthma and allergy. Arch. Intern. Med. 2007, 167, 821-827.
• 7. Cloud J., Kelly C. P.: Update on Clostridium difficile associated disease. Curr. Opin. Gastroenterol. 2007, 23, 4-9.
• 8. Cogen A. L., Nizet V., Gallo R. L.: Skin microbiota: a source of disease or defence? Br. J. Dermatol. 2008, 158, 442-455.
• 9. Cogen A. L., Nizet V., Gallo R. L.: Staphylococcus epidermidis functions as a component of the skin innate immune system by inhibiting the pathogen Group A Streptococcus. J. Invest. Dermatol. 2007, 127, S131.
• 10. Cukrowska B.: Zastosowanie probiotyków w chorobach o podłożu immunologicznym. Zakażenia 2009, 1, 31-36.
• 11. Cukrowska B., Czarnowska E.: Wpływ probiotyków na układ immunologiczny. Zakażenia 2007, 6, 2-6.
• 12. Domingo P., Fontanet A.: Management of complications associated with totally implantable ports in patients with AIDS. AIDS Patient Care STDS 2001, 15, 7-13.
• 13. Ekkelenkamp M. B., Hanssen M., Danny Hsu S. T., de Jong A., Milatovic D., Verhoef J., van Nuland N. A.: Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis. FEBS Lett. 2005, 579, 1917-1922.
• 14. Foster T. J.: Immune evasion by staphylococci. Nat. Rev. Microbiol. 2005, 3, 948-958.
• 15. Hartl D., Buckland K. F., Hogaboam C. M.: Chemokines in allergic aspergillosis - from animal models to human lung diseases. Inflamm. Allergy Drug Targets 2006, 5, 219-228.
• 16. Hiramitsu K.: Vancomycin-resistant Satphylococcus aureus: a new model of antibiotic resistance. Lancet. Infect. Dis. 2001, 1, 147-155.
• 17. Hooper L. V., Stappenbeck T. S., Hong C. V., Gordon J. I.: Angiogenins: a new class of microbiciadal proteins involved in innate immunity. Nat. Immunol. 2003, 4, 269-273.
• 18. Jugeau S., Tenaud I., Knol A. C., Jarrousse V., Quereux G., Khammari A., Dreno B.: Induction of Toll-like receptors by Propionibacterium acnes. Br. J. Dermatol. 2005, 153, 1105-1113.
• 19. Kalinowska-Gacek E., Gieryńska M.: Błony śluzowe - stan gotowości immunologicznej. Część I. Życie Wet. 2009, 84, 17-21.
• 20. Kim J.: Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology 2005, 211, 193-198.
• 21. Kusters J. G., van Vliet A. H., Kuipers E. J.: Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 2006, 19, 449-490.
• 22. Mazmanian S. K., Kasper D. L.: The love-hate relationship between bacterial polysaccharides and the host immune system. Nat. Rev. Immunol. 2006, 6, 849-858.
• 23. Mazmanian S. K., Round J. L., Kasper D. L.: A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453, 620-625.
• 24. Nagy I., Pivarsci A., Koreck A., Szell M., Urban E., Kemeny L.: Distinct strains Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J. Invest. Dermatol. 2005, 124, 931-938.
• 25. Packey C. D., Santor R. B.: Interplay of commensal and pathogenic bacteria, genetic mutations and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J. Int. Med. 2008, 263, 597-606.
• 26. Pamer G. E.: Immune response to commensal and environmental microbes. Nat. Immunol. 2007, 8, 1173-1178.
• 27. Postage J.: Cz³owiek i drobnoustroje. Wyd. Nauk. PWN, Warszawa 1994.
• 28. Ratner A. J., Lysenko E. S., Paul M. N., Weiser J. N.: Synergistic proinflammatory responses induced by polymicrobial colonization of epithelalial surfaces. Proc. Natl Acad. Sci. USA 2005, 102, 3429-3434.
• 29. Rivera A., Hohl T., Pamer E. G.: Immune responses to Aspergillus fumigatus infections. Biol. Blood Marrow Transplant. 2006, 12, 47-49.
• 30. Saijo S., Fujikado N., Furuta T., Chung S. H., Kotaki H., Seki K., Sudo K., Akira S., Adachi Y., Ohno N., Kinjo T., Nakamura K., Kawakami K., Iwakura Y.: Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 2007, 8, 39-46.
• 31. Salyers A. A., Witt D. D.: Mikrobiologia. Różnorodność, chorobotwórczość i środowisko. Wyd. Nauk. PWN, Warszawa 2003.
• 32. Taylor P. R., Tsoni S. V., Willment J. A., Dennehy K. M., Rosas M., Findon H., Haynes K., Steele C., Botto M., Gordon S.: Dectin-1 is required for β-glucan recognition and control of fungal infection. Nat. Immunol. 2007, 8, 31-38.
• 33. Voth D. E., Ballard J. D.: Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 2005, 18, 247-263.
• 34. Wang Q., McLoughlin R. M., Cobb B. A., Charrel-Dennis M., Zaleski J. K., Golenbock D., Tzianabos A. O., Kasper D. L.: A bacterial carbohydrate links and adaptive responses through Toll-like receptor 2. J. Exp. Med. 2006, 203, 2853-2863.
• 35. Witkowska D., Bartyś A., Gamian A.: Defensyny i katelicydyny jako naturalne antybiotyki peptydowe. Post. Hig. Med. Dośw. 2008, 62, 694-707.